认知行为疗法对肠易激综合征治疗获益的持久性与衰减:12个月随访
436例罗马III诊断的IBS患者随机接受4次家庭式CBT(MC-CBT)、10次门诊式CBT(S-CBT)或4次IBS教育(EDU),随访至治疗后12个月。MC-CBT和S-CBT分别有39%和33%的应答者在每次随访时维持治疗应答,EDU为19%,显著低于CBT组(p<0.05)。IBS-SSS显示所有条件下疗效趋于维持,基线与随访间平均单位降低在治疗后即刻约-76、12个月时约-94(-50为临床显著)。
要点
- MC-CBT和S-CBT分别有39%和33%的应答者在每次随访维持应答,EDU为19%(p<0.05)。
- IBS-SSS平均降低在治疗后即刻约-76、12个月约-94,-50为临床显著阈值。
- 对治疗难治性IBS,家庭式和门诊式CBT均带来substantial且持久的多种症状缓解,一般延续至治疗后12个月。
核心结论
- 对治疗难治性IBS患者,家庭式和门诊式CBT均带来substantial且持久的多种IBS症状缓解,一般延续至治疗后12个月。
研究设计与样本
- 随机对照试验,共436例罗马III诊断的IBS患者(80%女性,平均年龄41岁),随机分为4次家庭式CBT(MC-CBT)、10次门诊式CBT(S-CBT)或4次IBS教育(EDU)。
- 随访在治疗完成后2周及3、6、9、12个月进行。
- 治疗应答基于临床总体改善量表(CGI,整体IBS症状改善)和IBS症状严重度量表(IBS-SSS)预先设定。
主要发现
- MC-CBT患者在12个月随访期间各季度CGI获益一般维持,衰减可忽略。
- MC-CBT和S-CBT分别有39%和33%的应答者在每次随访评估时维持治疗应答,EDU对应比例为19%,显著低于CBT组(p<0.05)。
- IBS-SSS上,所有条件下治疗获益均呈维持模式,并趋于随时间疗效增加,基线与随访间平均单位降低在治疗后即刻约-76、12个月时约-94(-50为临床显著)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is a need for safe and effective IBS treatments that provide immediate and sustained improvement of IBS symptoms, particularly among more severe patients. The aim was to assess long-term clinical response of cognitive behavioral therapy (CBT) with reference to IBS education. METHODS: A total of 436 Rome III-diagnosed IBS patients (80% F, M age = 41 years) were randomized to: 4 session home-based CBT (minimal contact (MC-CBT)), 10 session clinic-based CBT (standard (S-CBT)), or 4 session IBS education (EDU). Follow-up occurred at 2 weeks and 3, 6, 9, and 12 months following treatment completion. Treatment response was based a priori on the Clinical Global Improvement Scale (global IBS symptom improvement) and IBS Symptom Severity Scale (IBS-SSS). RESULTS: Post-treatment CGI gains were generally maintained by MC-CBT patients at quarterly intervals through 12-month follow-up with negligible decay. For MC-CBT and S-CBT, 39 and 33% of respondents maintained treatment response at every follow-up assessment. The corresponding percent for EDU was 19%, which was significantly lower (p < 0.05) than for the CBT groups. On the IBS-SSS, therapeutic gains also showed a pattern of maintenance with trends towards increased efficacy over time in all conditions, with the mean unit reductions between baseline and follows-up being approximately -76 at immediate and approximately -94 at 12 months (-50 = clinically significant). CONCLUSIONS: For treatment-refractory IBS patients, home- and clinic-based CBT resulted in substantial and enduring relief of multiple IBS symptoms that generally extended to 12-month post treatment.
引用
- Lackner JM, Jaccard J, Radziwon CD, et al. Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up. Am J Gastroenterol. 2019. PMID: 30429592. doi:10.1038/s41395-018-0396-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。